Interaction of Body Mass Index and Glycemic Status on Cardiovascular Outcomes in Patients With Cancer Treated With Anthracyclines
In patients with cancer undergoing anthracycline-based chemotherapy, both body mass index and glycemic status significantly affect cardiovascular risks, with the highest risk observed in those with concurrent obesity and diabetes/prediabetes, emphasizing the need for tailored risk assessment and management.
Authors
- Rongrong Gao (ORCID: https://orcid.org/0000-0002-2323-418X)
- Mei‐Zhen Wu
- Q W Ren (ORCID: https://orcid.org/0000-0003-0712-9299)
- Xu Zhu (ORCID: https://orcid.org/0000-0002-4347-3639)
- Gehui Ni (ORCID: https://orcid.org/0000-0002-4965-131X)
- Xinyi Lu (ORCID: https://orcid.org/0000-0001-5961-6625)
- Iokfai Cheang (ORCID: https://orcid.org/0000-0002-9950-9696)
- Xinli Li (ORCID: https://orcid.org/0000-0002-7889-6359)
- Ying Yang (ORCID: https://orcid.org/0000-0002-3751-2590)
- Yue Zhang (ORCID: https://orcid.org/0009-0005-8105-7803)
- Kai‐Hang Yiu
- Ying Li (ORCID: https://orcid.org/0009-0006-2882-4054)
Institutions
- Queen Mary Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1161/jaha.124.040876
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00